Study on the relationship between the expression of TSP-1, VEGF, and plasma inflammatory factors and early acute lung injury in COPD
10.3969/j.issn.1006-2483.2021.06.007
- VernacularTitle:TSP-1、VEGF表达及血浆相关炎症因子与慢性阻塞性肺疾病早期急性肺损伤关系
- Author:
Chenyuan DONG
1
;
Fuquan ZHANG
1
;
Songfeng ZHU
1
Author Information
1. Respiratory Disease Prevention and Treatment Institute , Respiratory Tuberculosis Department , Pingdu , Shandong 266700 , China
- Publication Type:Journal Article
- Keywords:
Acute lung injury;
Thrombin sensitive protein 1;
Vascular endothelial growth factor;
Interleukin;
Chronic obstructive pulmonary disease;
Correlation
- From:
Journal of Public Health and Preventive Medicine
2021;32(6):29-32
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the relationship between the expression of TSP-1, VEGF, and Th17-related inflammatory factors and early acute lung injury (ALI) in COPD. Methods The clinical data of 140 randomly selected patients with COPD in our hospital from May 2016 to June 2018 were retrospectively analyzed. According to the condition of the disease, they were divided into control group (n = 70) and observation group (n = 70). The related indicators were determined by flow cytometry and enzyme-linked immunosorbent assay (ELISA). Statistical analysis of data was carried out by Pearson linear correlation analysis and logistic regression analysis. Results Compared with the control group, the levels of FEV1 and FEV1/FVC in the patients with COPD complicated with early ALI were significantly lower, while the ratio of Th17/Treg in peripheral blood was significantly higher in the observation group. The plasma levels of TSP-1, VEGF and related inflammatory factors were significantly higher in the observation group than those in the control group. Pearson correlation analysis showed that TSP-1 and VEGF were positively correlated with CD4+Th17 cell ratio. Logistic regression analysis showed that IL-17 was an independent risk factor for early acute lung injury in COPD. Conclusion The increased release of Th17-related inflammatory cytokines will aggravate the airway inflammatory response, cause abnormal expression of TSP-1 and VEGF, and lead to vascular endothelial dysfunction, which will further aggravate the condition of patients, and increase the risk of acute lung injury in patients with COPD.
